Found: 7
Select item for more details and to access through your institution.
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.
- Published in:
- Oncology, 2020, v. 98, n. 12, p. 836, doi. 10.1159/000502482
- By:
- Publication type:
- Article
Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.
- Published in:
- Oncology, 2017, v. 93, n. 4, p. 233, doi. 10.1159/000455957
- By:
- Publication type:
- Article
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-77939-6
- By:
- Publication type:
- Article
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 6, p. 969, doi. 10.1007/s00259-016-3583-2
- By:
- Publication type:
- Article
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 1403, doi. 10.2147/OTT.S111681
- By:
- Publication type:
- Article
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 773, doi. 10.2147/OTT.S91977
- By:
- Publication type:
- Article
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0616-2
- By:
- Publication type:
- Article